期刊文献+

浅谈WHO国家疫苗监管体系评估及其上市许可板块要求 被引量:5

A brief discussion on requirements of the marketing authorization and license activities function from National Regulatory Authority Assessment of WHO
下载PDF
导出
摘要 通过卫生组织国家疫苗监管体系(National Regulatory Authority)评估是一个国家疫苗具备参与联合国全球采购资格的必要条件。本文对WHO国家疫苗监管体系评估整体加以简述,重点对上市许可板块指标进行归纳,通过探讨WHO国家疫苗监管体系评估上市许可部分的管理理念,以期为疫苗监管相关部门加强自身管理提升监管质量和效率有所提示。 It is essential to pass through the national regulatory authority (NRA) assessment of WHO for the country to be qualified for vaccine supply to the United Nations agencies. Though the introduction of the NRA system and the discussion on the market authorization and licensing activities function, this paper is drafted to hint the think points of WHO, which may be benefit for the quality management system of our national regulatory system.
出处 《微生物学免疫学进展》 2012年第3期67-72,共6页 Progress In Microbiology and Immunology
关键词 疫苗 国家监管体系评估 上市许可 质量管理体系 Vaccine National Regulatory Authority (NRA) Marketing authorization and licensing activities Qualitymanagement system
  • 相关文献

参考文献5

  • 1WHO. A WHO manual for assessment of the national regulatory system for vaccines, draft _ manual _ NRA _ assessment _ part _ 3 _ 31 August2009rev3 [ S].
  • 2中国食品药品检定研究院.马霄副研究员赴埃及参加WHO对埃及“国家疫苗监管体系”正式评估.http://www.nicpbp.org.cn/CL0011/2452.html.
  • 3WHO. NRA assessment tools ( Revision Y 2007 - R05,23 Septem- ber 2009 ) [ S ].
  • 4Procedures for assessing the acceptability in principle of vaccines for purchase by United agencies, ~ 2006-06 ] [ S ]. http ://www. who. int/vaccines-documents/DocsPDF06/812, pdf.
  • 5中华人民共和国国家质量监督检验检疫总局,中国国家标准化管理委员会.GB/T19001-2008idtIS09001:2008[S].

同被引文献19

  • 1World Health Organization. Procedures for assessing the accepta- bility, in principle, of vaccines for purchase by United Nations agencies ( WHO/BS/10.2155 ) [ EB/OL ]. [ 2012- 06- 01 J. ht- tp://www, who. int/innunazation_standards/vaccine_quality/pq _revision2010/en/.
  • 2World Health Organization. Vaccines prequalification priority list 2013-14 [ EB/OL]. http ://www. who. int/inanunization _ stand- ards/vaceine _ quality/priority_pq vaccines_2013_ 14/en/.
  • 3Global Polio Eradication Initiative. Polio Eradication and ending strategic plan, 2013-2018 [ EB/OL]. http://www, polioeradica- tion. org/ Strat Plan 20130409_ENG. pdf strategyWork/Endgame.
  • 4World Health Organization. ECBS Technical Report Series:vac- cines [ EB/OL ]. http://www, who. int./ bialogicals/publica- tions/trs/areas/vaccines/en/index, html.
  • 5World Health Organization. WHO prequalification: information and guidance documents for vaccine manufactures [ EB/OL ]. http://www, who. int/immunization _ standards/vaccine _ quali- ty/PQ_vaccine manufactures_guidence/en/.
  • 6World Health Organization. Recommendations for the evaluation of animal cell cultures as substrates for the manufacture of biological medicinal products and for the characterization of cell banks ( WHO/TRS/978 ) [ EB/OL ]. http://www, who. int/biologi- cals/vaccines/TRS_978_ Annex_3. pdf.
  • 7World Health Organization. Points to consider for manufacturers of human vaccines : clinical considerations for evaluation of vaccines for prequalification [ EB/OL ]. http ://www. who. int/ immuniza- tion _ standards/vaccine _ quality/pq _ vaccine _ evaluation/en/in- dex. html.
  • 8ICH. Comparability of biotechnological/biological products sub- ject to changes in their manufacturing process (CPMP/ICH/ 5721~03 ) [ S]. 2005.
  • 9王福清,易静薇,赵晓嬿,张春颖.我国疫苗产业发展现状与展望[J].中国生化药物杂志,2009,30(4):287-288. 被引量:15
  • 10侯永芳,王玲,郭秀花,杜晓曦.信号检测在药品不良反应监测系统中的应用[J].中国药物警戒,2012,9(9):539-541. 被引量:25

引证文献5

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部